Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously.

Source:http://linkedlifedata.com/resource/pubmed/id/19732370

Download in:

View as

General Info

PMID
19732370